Parents Helping Parents Program for Youth Vaping Cessation
(PhP-VX Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a program designed to help teens quit vaping by involving their parents in a supportive role. It focuses on a peer support system where trained parent coaches guide parents. The trial compares two groups: one with the Parents Helping Parents program and one without it. This trial suits parents who often see their teens vaping and want to help them stop, especially if they can meet face-to-face with their teen at least once a week. As an unphased trial, this study offers families a unique opportunity to explore new support strategies in a collaborative environment.
Will I have to stop taking my current medications?
The trial information does not specify whether participants need to stop taking their current medications.
What prior data suggests that the Parents Helping Parents program is safe for youth vaping cessation?
Research has shown that the Parents Helping Parents (PhP-VX) program aids teens in quitting vaping by offering peer support for parents. As a behavioral program rather than a medication, it does not have known physical side effects like those associated with drugs.
The primary concern may be how well parents and teens adapt to the program. However, similar programs have reported no harm or negative effects. Since this trial tests a support program and not a new drug, safety risks are expected to be low. Researchers will monitor participants to ensure the program remains both helpful and safe.12345Why are researchers excited about this trial?
Researchers are excited about the Parents Helping Parents (PhP-VX) program because it offers a fresh approach to youth vaping cessation by actively involving parents in the process. Unlike traditional methods that primarily focus on individual counseling or nicotine replacement therapies, this program empowers parents to support and guide their children in quitting vaping. This collaborative, family-centered strategy is unique and may enhance motivation and accountability, potentially leading to more effective and sustainable outcomes for teens trying to quit vaping.
What evidence suggests that the Parents Helping Parents program is effective for youth vaping cessation?
Research shows that involving parents can help teens quit vaping. In this trial, participants in the Test Group will receive the Parents Helping Parents (PhP-VX) program, designed to support parents by connecting them with other parents for advice and encouragement. Although limited data exists on this specific program, similar methods, such as sending personalized text messages, have successfully helped teens stop vaping. The PhP-VX program incorporates these ideas by focusing on parental involvement and peer support, which are promising ways to change behavior. Early results suggest that this approach could effectively assist teens in quitting vaping.12346
Are You a Good Fit for This Trial?
This trial is for parents of adolescents who are currently vaping. Parents must be willing to participate in surveys and engage with the program, which includes receiving peer support from trained parent coaches.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Participants complete a baseline survey assessing e-cigarette and tobacco use, vaping knowledge, and exposure to marketing and media
Treatment
Parents in the intervention arm receive the PhP-VX program, including online lessons and six bi-weekly, 30-minute, 1:1 coach-facilitated sessions via Zoom
Follow-up
Participants are monitored for e-cigarette use, vaping knowledge, and marketing/media literacy at months 1, 3, and 6
Optional Biochemical Verification
Adolescents may provide saliva samples at baseline, 3 months, and 6 months for cotinine testing
What Are the Treatments Tested in This Trial?
Interventions
- Parents Helping Parents program
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Nebraska
Lead Sponsor
National Cancer Institute (NCI)
Collaborator
Massachusetts General Hospital
Collaborator